Orathecin (rubitecan) is an anti-cancercompound developed by Stehlin Foundation researchers and patented as 9-NitroCamptothecin. This oral chemotherapy agent has been co-investigated by the Stehlin Foundation and SuperGen Incorporation as a treatment for patients with pancreatic cancer who have failed at least one prior chemotherapy. It is a great achievement for any cancer research laboratory to take a drug all the way from initial development, through their search, clinical trials, patentin...
| Currently you cannot purchase Orthecin as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Orthecin |
| Orthecin Availability Subscription Form |
|
| |
| Note: We will email you when Orthecin is available for sale online or in pharmacy in your country. |
|
|
|
|
